Exposure and response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial

Exposure and response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial

IntroductionThe aim of this study was to directly compare behavior therapy (exposure & response prevention; ERP) with pharmacotherapy (risperidone) with respect to tic severity and quality of life in patients with Tourette's disorder or tic disorders.MethodA total of 30 participants wer...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jolande M. T. M. van de Griendt, Danielle C. Cath, Agnes A. A. C. M. Wertenbroek, Cara W. J. Verdellen, Judith J. G. Rath, Irene G. Klugkist, Sebastiaan F. T. M. de Bruijn, Marc J. P. M. Verbraak
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Psychiatry
Subjects:	tics Tourette’s disorder risperidone behavior therapy exposure and response prevention
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1360895/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Histological and Biochemical Changes in Ovaries of Adult Wistar Rats Following Exposure to Risperidone
by: Onyilo, P.O.*, Dirisu, E.I., Samuel, B.O.
Published: (2024-11-01)

Efficacy and safety of risperidone oral solution in agitation associated with dementia in the elderly
by: Jerson Laks, et al.
Published: (2001-12-01)

Flash Chromatography Application for Risperidone Purification
by: G. S. Trush, et al.
Published: (2015-08-01)

The maintenance of modified electroconvulsive therapy combined with risperidone is better than risperidone alone in preventing relapse of schizophrenia and improving cognitive function
by: Ying Yang, et al.

Risperidone oral disintegrating mini-tablets: A robust-product for pediatrics
by: El-Say Khalid M., et al.
Published: (2015-12-01)

Risperidone-induced Premature Ventricular Complexes in Psychosis: A Case Report
by: Javed A Siddiqui, et al.
Published: (2023-06-01)

Formulation of Risperidone Nano Niosomal Vesicular System by Ecofriendly Direct Ultrasonication Method
by: Mohamed I. Al- Shadedi, et al.
Published: (2025-06-01)

Advanced Drug Delivery Technologies for Enhancing Bioavailability and Efficacy of Risperidone
by: Rathi R, et al.
Published: (2024-11-01)

Bioequivalence study of tablet forms of risperidone, olanzapine and quetiapine in healthy volunteers
by: V. V. Pisarev, et al.
Published: (2013-04-01)

Activation of osteoblast ferroptosis by risperidone accelerates bone loss in mice models of schizophrenia
by: Hongyan Fan, et al.
Published: (2025-01-01)

Advanced LC-MS/MS method for selective quantification of nitrosamine impurities in Risperidone: Enhancing drug safety
by: Hitesh Thumbar, et al.
Published: (2025-08-01)

Risperidone-induced Myoclonus in a Young Patient with Schizophrenia
by: Aman Naqvi, et al.
Published: (2025-01-01)

Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
by: Yi-Ting Yeh, et al.
Published: (2025-07-01)

Comparative Efficacy of Lorazepam and Risperidone in Hospitalized Cannabis-induced Psychotic Disorder
by: Arshdeep Jhalli, et al.
Published: (2024-02-01)

Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic Review
by: Ana Carrascosa-Arteaga, et al.
Published: (2025-05-01)

A hybrid model for predicting response to risperidone after first-episode psychosis
by: Giovany Oliveira Costa, et al.
Published: (2025-03-01)

Chemical and Toxicological Diagnosis of Acute Poisoning with Clozapine, Olanzapine, Quetiapine and Risperidone
by: M. V. Belova, et al.
Published: (2020-10-01)

Clonidine and Levetiracetam for Tics Compared
by: J Gordon Millichap
Published: (2009-06-01)

Advances in Clustering and Classification of Tic Disorders: A Systematic Review
by: Yang K, et al.
Published: (2024-12-01)

Reutericyclin, a specialized metabolite of Limosilactobacillus reuteri, mitigates risperidone-induced weight gain in mice
by: Fatima A. Aboulalazm, et al.
Published: (2025-12-01)

Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone
by: Francisco José Toja-Camba, et al.
Published: (2024-10-01)

Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1/2-Nrf2-caspase-3 signaling pathway
by: Reham H. Mohyeldin, et al.
Published: (2025-04-01)

Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism
by: Eman A. E. Farrag, et al.
Published: (2024-09-01)

MRI-based insights into brain structural and functional alterations in schizophrenia treated with risperidone
by: Hangyu Li, et al.
Published: (2025-06-01)

Ekbom Syndrome Management in Elderly Patients: Challenges in Risperidone Titration and Treatment Adherence
by: Florina Madalina Mindru, et al.
Published: (2025-03-01)

Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophrenia
by: Itay Perlstein, et al.
Published: (2025-03-01)

Use of gold/iron metal-organic framework nanoparticles (AuNPs/FeMOF)-modified glassy carbon electrode as an electrochemical sensor for the quantification of risperidone in patient plasma samples
by: Zahra Golsanamlu, et al.
Published: (2025-05-01)

Tics and Tourette syndrome: clinical evaluation of 44 cases
by: Teive Hélio A.G., et al.
Published: (2001-01-01)

Clinical Utility of Long-Acting Injectable Risperidone in Schizophrenia and Bipolar I Disorder: A Review of Clinical Studies
by: Bartoli F, et al.
Published: (2025-06-01)

A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
by: Emi Hata, et al.
Published: (2025-01-01)

Simple and Complex Phonic Tics in Tourette Syndrome
by: José Fidel Baizabal-Carvallo, et al.
Published: (2025-06-01)

The prevalence of tic disorders in children and adolescents in Brazil
by: Helvio L. Alves, et al.
Published: (2014-12-01)

Neuroanatomical and functional correlates in tic disorders and Tourette's syndrome: A narrative review
by: Anna Sara Liberati, et al.
Published: (2024-12-01)

The role of inflammation in the development of tic symptoms in subjects with ADHD
by: Nagahide Takahashi, et al.
Published: (2025-05-01)

Does Repeated Ticking Maintain Tic Behavior? An Experimental Study of Eye Blinking in Healthy Individuals
by: Daniel J. V. Beetsma, et al.
Published: (2014-01-01)

Psychosocial stress in children with Tourette syndrome and chronic tic disorder
by: Chiew Yin Tan, et al.
Published: (2024-07-01)

Recalculation of the budgetary impact of risperidone use for Autism Spectrum Disorder: a case study using measured demand data, Brazil, 2017-2019
by: Luis Phillipe Nagem Lopes, et al.
Published: (2025-07-01)

An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans
by: Lilach Steiner, et al.
Published: (2025-01-01)

Neurodevelopmental Tics with Co-Morbid Functional Tic-like Behaviors: Diagnostic Challenges of a Complex Tourette Syndrome Phenotype
by: Andrea Eugenio Cavanna, et al.
Published: (2025-04-01)

Complex phonic tic and disinhibition in Tourette syndrome: case report
by: Débora Palmini Maia, et al.
Published: (2001-09-01)